CC — The Chemours Company

Summary of The Chemours Company Q4 2025 Earnings Call

1. Key Financial Results and Metrics

• Net Sales: Met expectations, driven by record sales in the TSS segment, particularly from Opteon refrigerants.
• Free Cash Flow: Strong generation of $92 million, indicating robust cash generation potential.
• Adjusted EBITDA: Margins for TSS improved to 32%, up from 31% year-over-year.
• Earnings: Missed the low end of the earnings range due to non-cash charges and inventory management strategies in the APM segment.

2. Strategic Updates and Business Highlights

• Kuan Yin Site Sale: Agreement to sell the Kuan Yin site for estimated net proceeds of $300 million, aimed at reducing debt and improving leverage ratios.
• Leadership Changes: Appointment of Mike Foley as Business President of the Titanium Technologies (TT) segment, expected to enhance operational excellence.
• Pathway to Thrive Strategy: Continued focus on operational excellence, cost reduction, and cash flow generation, with a goal of achieving at least $125 million in gross controllable cost savings in 2025.

3. Forward Guidance and Outlook

• 2026 Projections:
  • Net Sales Growth: Expected to increase by 3% to 5% year-over-year.
  • Adjusted EBITDA: Anticipated to range from $800 million to $900 million, driven by demand in TSS and APM segments.
  • Free Cash Flow: Expected conversion above 25%, with capital expenditures projected between $275 million and $325 million.
  • First Quarter Guidance: Net sales expected to rise 3% to 5% sequentially, with adjusted EBITDA anticipated between $121 million and $150 million.

4. Bad News, Challenges, or Points of Concern

• APM Segment Weakness: Facing near-term end market weakness, particularly in auto and industrial construction, leading to cash flow-driven changes that impacted earnings.
• Washington Works Facility Disruption: Temporary shutdown due to utility service outage, which negatively affected capacity and is expected to impact Q1 results by $20 million to $25 million.
• Inventory Levels: Increased inventory levels compared to previous years, raising concerns about efficiency and cash flow management.
• Market Conditions: Anticipated stable demand with no significant growth triggers, particularly in the TT segment, where volume growth is expected to be in line with industry averages.

5. Notable Q&A Insights

• TT Segment Volume Growth: Management indicated stable demand with a focus on pricing power rather than volume increases, with expectations of flat pricing entering Q1.
• Legacy Liabilities: Progress made in resolving legacy liabilities, with expectations for continued updates throughout 2026.
• Antidumping Duties: Management expressed confidence in the benefits from antidumping duties in various regions, particularly in Brazil, while acknowledging challenges in India and Europe.
• Free Cash Flow Expectations: Management indicated confidence in achieving free cash flow targets despite seasonal working capital outflows expected in Q1.

Overall, The Chemours Company reported solid cash flow and strategic progress, but faces challenges in certain segments and market conditions that may impact future performance.